Freenome, Inc.(FRNM)

Medical - Diagnostics & Research · Brisbane, CA

$16.71-0.12 (-0.71%)

Delayed quote: Oct 6, 2026, 2:30 PM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T18:31:26.623Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:31:26.623Z.

Quote observation: 2026-10-06T18:30:03.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 136,307,514
Total debt: N/A
Cash: N/A
TTM free cash flow: N/A

FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

FRNM EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

FRNM Competitors' EV/FCF Ratio

FRNM

Freenome, Inc.

Current

Market Cap

$136.31M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OGI

Organigram Global Inc.

vs FRNM

Market Cap

$136.54M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KRMD

KORU Medical Systems, Inc.

vs FRNM

Market Cap

$137.80M

EV/FCF Ratio

503.85x

TTM Avg

1051.55x

3Y Avg

1051.55x

5Y Avg

1051.55x

RNA

Atrium Therapeutics, Inc.

vs FRNM

Market Cap

$137.70M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LFMD

LifeMD, Inc.

vs FRNM

Market Cap

$133.72M

EV/FCF Ratio

N/A

TTM Avg

61.40x

3Y Avg

555.49x

5Y Avg

549.31x

AIRS

AirSculpt Technologies, Inc.

vs FRNM

Market Cap

$132.98M

EV/FCF Ratio

242.92x

TTM Avg

151.93x

3Y Avg

133.72x

5Y Avg

94.60x

ACOG

Alpha Cognition Inc

vs FRNM

Market Cap

$138.85M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HCAT

Health Catalyst, Inc.

vs FRNM

Market Cap

$133.01M

EV/FCF Ratio

18.56x

TTM Avg

24.01x

3Y Avg

24.01x

5Y Avg

24.01x

STRO

Sutro Biopharma, Inc.

vs FRNM

Market Cap

$141.68M

EV/FCF Ratio

N/A

TTM Avg

31.12x

3Y Avg

31.12x

5Y Avg

31.12x

IMRX

Immuneering Corporation

vs FRNM

Market Cap

$140.91M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Freenome, Inc. (FRNM)	$136.31M	N/A	N/A	N/A	N/A
Organigram Global Inc. (OGI)vs ›	$136.54M	N/A	N/A	N/A	N/A
KORU Medical Systems, Inc. (KRMD)vs ›	$137.80M	503.85x	1051.55x	1051.55x	1051.55x
Atrium Therapeutics, Inc. (RNA)vs ›	$137.70M	N/A	N/A	N/A	N/A
LifeMD, Inc. (LFMD)vs ›	$133.72M	N/A	61.40x	555.49x	549.31x
AirSculpt Technologies, Inc. (AIRS)vs ›	$132.98M	242.92x	151.93x	133.72x	94.60x
Alpha Cognition Inc (ACOG)vs ›	$138.85M	N/A	N/A	N/A	N/A
Health Catalyst, Inc. (HCAT)vs ›	$133.01M	18.56x	24.01x	24.01x	24.01x
Sutro Biopharma, Inc. (STRO)vs ›	$141.68M	N/A	31.12x	31.12x	31.12x
Immuneering Corporation (IMRX)vs ›	$140.91M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

FRNM EV/FCF Ratio Metrics

FRNM Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics